Global Cerebral Vascular Stent Market

Cerebral Vascular Stent Market Size, Share, Growth Analysis, By Material(Tantalum, Stainless Steel, Nitinol), By End User(Hospitals, Ambulatory Surgical Centers, Medical Centres, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35B2192 | Region: Global | Published Date: April, 2024
Pages: 217 | Tables: 64 | Figures: 72

Cerebral Vascular Stent Market News

  • In February 2022, CERENOVUS, a part of the Johnson & Johnson Medical Device companies, announced the launch of a new catheter for the treatment of acute ischemic stroke.
  • In June 2022, Medtronic, a leading name in the healthcare device business, announced the launch of a new embolization device to treat brain aneurysms in India. The new flow diverter was also equipped with Sheild Technology.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cerebral Vascular Stent Market size was valued at USD XX million in 2022 and is poised to grow from USD XX million in 2023 to USD XX million by 2031, growing at a CAGR of 8.2% in the forecast period (2024-2031).

Cerebral vascular stent market players should invest heavily in product innovation and R&D to expand their product portfolio and stay competitive in the marketplace. Cerebral vascular stent providers can also focus on making their products more affordable to maximize their sales and revenue generation potential going forward. Cerebral vascular stent manufacturers can also partner and collaborate with health insurance companies to improve reimbursement potential and promote market development as well. 'W.L. Gore & Associates', 'Stryker Corporation', 'Terumo Corporation', 'Biotronik SE & Co. KG', 'Medtronic', 'Phenox GmbH', 'Abbott Laboratories', 'B. Braun Melsungen AG', 'Cordis Corporation', 'Acandis GmbH', 'Boston Scientific Corporation', 'Cook Medical', 'Johnson & Johnson Services, Inc.', 'Penumbra Inc.', 'MicroPort Scientific Corporation', 'C.R. Bard', 'Cook Medical'

Older people are more at risk of requiring cerebral and vascular treatments and as their population increases around the world, it will also promote the demand for cerebral vascular stents as well.

North America is estimated to account for a major chunk of the cerebral vascular stent demand outlook owing to the presence of a developed healthcare infrastructure and rapidly increasing incidence of cerebral disorders. High investments in medical R&D and growing availability of novel treatments in this region are also slated to help its dominance of the cerebral vascular stent market going forward. The United States is predicted to spearhead cerebral vascular stent sales followed by Canada over the coming years.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Coronary Stent Market
Buy Now GET FREE SAMPLE
Stents Market
Buy Now GET FREE SAMPLE
Aortic Stent Grafts Market
Buy Now GET FREE SAMPLE
Gastrointestinal Stents Market
Buy Now GET FREE SAMPLE
Branched Stent Grafts Market
Buy Now GET FREE SAMPLE
Peripheral Artery Disease Market
Buy Now GET FREE SAMPLE
Vascular Patches Market
Buy Now GET FREE SAMPLE
Neurovascular Devices Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Cerebral Vascular Stent Market

Report ID: SQMIG35B2192

$5,300
BUY NOW GET FREE SAMPLE